| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5.1B | $5.4B | $9.6B | $7.3B | $3.1B | $1.0B | $0.9B | $0.9B |
| Cost of Revenue | $4.5B | $5.3B | $8.4B | $4.2B | $2.1B | $2.3B | $2.2B | — |
| Gross Profit | $0.7B | $0.1B | $1.2B | $3.1B | $1.0B | $0.3B | $0.3B | $0.3B |
| R&D Expense | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| SG&A Expense | $0.6B | $0.6B | $0.9B | $0.5B | $0.4B | $0.5B | $0.4B | $0.4B |
| Operating Income | $-0.4B | $-1.8B | $0.3B | $2.5B | $0.5B | $0.7B | $0.9B | $0.6B |
| Net Income | $-0.5B | $-1.2B | $1.6B | $2.7B | $0.4B | $0.1B | $0.1B | $-0.2B |
| EPS (Basic) | $-5.76 | $-11.20 | $13.41 | $22.97 | $3.53 | $5.03 | $6.40 | $0.49 |
| EPS (Diluted) | $-5.76 | $-11.20 | $13.36 | $22.84 | $3.52 | $5.02 | $6.34 | $0.49 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $16.4B | $16.6B | $18.3B | $15.5B | $10.5B | $9.9B | $7.6B | $7.8B |
| Current Assets | $4.0B | $3.8B | $5.2B | $5.2B | $2.2B | $2.2B | $2.0B | $2.5B |
| Cash & Equivalents | — | — | — | — | — | $0.6B | $0.6B | $1.1B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $1.8B | $2.0B | $3.6B | $2.7B | $1.8B | $1.4B | $1.2B | $1.2B |
| Stockholders' Equity | $9.5B | $10.0B | $9.4B | $8.0B | $4.3B | $3.9B | $3.6B | $3.7B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.3B | $0.7B | $1.3B | $1.9B | $0.8B | $0.7B | $0.5B | $0.3B |
| Investing Cash Flow | $-0.1B | $-1.6B | $-2.8B | $-1.4B | $-0.9B | $-1.7B | $-0.3B | $-0.4B |
| Capital Expenditures | $0.6B | $1.7B | $2.1B | $1.3B | $0.9B | $0.9B | $0.7B | $0.3B |
| Financing Cash Flow | $-0.8B | $1.2B | $0.6B | $0.6B | $0.2B | $1.0B | $-0.8B | $-1.1B |